Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting

PaperCitations, authors & open-access status

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 95 citations, 2017 year and gold oa status.

95
Citations
2017
Year
gold
OA Status

Related on ScholarIQ

Caroline McKay
Author
PLoS ONE
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Diagnosis and Treatment
Topic
470M+ articles · free account